Pathogenesis, detection and treatment of Achilles tendon xanthomas

European Journal of Clinical Investigation

Volumn 35, Issue 4, 2005, Pages 236-244

  Tsouli, S G ^a   Kiortsis, D N ^a   Argyropoulou, M I ^a   Mikhailidis, D P ^b   Elisaf, Moses S ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Achilles tendon xanthomas; Atherosclerosis; Familial hypercholesterolaemia

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; ATORVASTATIN; BEZAFIBRATE; CHOLESTEROL; CHOLESTEROL ESTER; CLOFIBRATE; COLLAGEN; CYTOCHROME P450; ESTROGEN; FIBRIC ACID DERIVATIVE; GLYCOSAMINOGLYCAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MEVINOLIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PRAVASTATIN; PROBUCOL; ROSUVASTATIN; SIMVASTATIN; STEROL 27 HYDROXYLASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ACHILLES TENDON; ATHEROMA; BIOACCUMULATION; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; ECHOGRAPHY; ESTROGEN ACTIVITY; FAMILIAL HYPERCHOLESTEROLEMIA; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; LIPID METABOLISM; LIVER TRANSPLANTATION; MACROPHAGE; METABOLIC DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PHAGOCYTOSIS; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TUMOR LOCALIZATION; XANTHOMA;

ACHILLES TENDON; ARTERIOSCLEROSIS; CHOLESTEROL; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS, LDL; MAGNETIC RESONANCE IMAGING; MUSCULOSKELETAL DISEASES; XANTHOMATOSIS;

EID: 17444398612     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01484.x     Document Type: Review

References (81)

1. Takahashi K, Naito M. Lipid storage disease: Part I. Ultrastructure of xanthoma cells in various xanthomatous diseases. Acta Pathol Jpn 1983;33:959-77.
2. Bhattacharyya AK, Preacher AB, Connor WE. Ectopic xanthomas in familial (type II) hypercholesterolemia. Atherosclerosis 1980;37:319-23.
3. Vermeer BJ, Mateysen AA, van Gent CM, van Sabben RM, Emeis JJ. The lipid composition and localization of free and esterified cholesterol in different types of xanthomas. J Invest Dermatol 1982;78:305-8.
4. Heiberg A. The lipoprotein and lipid pattern in xanthomatosis. Acta Med Scand 1975;198:183-95.
5. Haacke H, Parwaresch MR. Spontaneous rupture of the Achilles tendon - a sign of hyperlipoproteinaemia (HLP) type II. Klin Wochenschr 1979;57:397-400.
6. Mabuchi H, Ito S, Haba T, Ueda K, Ueda R. Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by Achilles' tendon thickness. Atherosclerosis 1977;28:61-8.
7. Myant NB, Slack J, Type II hyperlipoproteinaemia. Clin Endocrinol Metab 1973;2:81-109.
8. Yamakawa K, Yanagi H, Saku K, Sasaki J, Okafuji T, Shimakura Y et al. Family studies of the LDL receptor gene of relatively severe hereditary hypercholesterolemia associated with Achilles tendon xanthomas. Hum Genet 1991;86:445-9.
9. Descamps OS, Leysen X, Van Leuven F, Heller FR. The use of Achilles tendon ultrasonography for the diagnosis of familial hypercholesterolemia. Atherosclerosis 2001;157:514-8.
10. Leung N, Hegele RA, Lewis GF. Rapid development of massive tendon xanthomas following highly active antiretroviral therapy. Ann Intern Med 2002;137:624.
11. Al-Kateb H, Bahring S, Hoffmann K, Strauch K, Busjahn A, Nurnberg G et al. Mutation in the ARH gene and a chromosome 13q locus influence cholesterol levels in a new form of digenic-recessive familial hypercholesterolemia. Circ Res 2002;90:951-8.
12. Zuliani G, Area M, Signore A. Characterization of a new form of inherited hypercholesterolemia. Arteriosder Thromb Vasc Biol 1999;19:802-9.
13. Ueyama Y, Nozaki S, Yanagi K, Hiraoka H, Nakagawa T, Sakai N et al. Familial hypercholesterolaemia-like syndrome with apolipoprotein E-7 associated with marked Achilles tendon xanthomas and coronary artery disease: a report of two cases. J Intern Med 1994;235:169-74.
14. Monganroth J, Levy RI, Fredrickson DS. The biochemical, clinical and genetic features of type III hyperlipoproteinemia. Ann Intern Med 1975;82:158-74.
15. Fredrickson DS, Goldstein JS, Brown MS. The familial hyperlipoproteinemias. In: Standbury JD, Wyungaarden JB, Fredrickson DS, editors. The Metabolic Basis of Inherited Disease. New York: Mcgrraw-Hill Book Company; 1978.pp. 604-55.
16. Michal M, Fanburg-Smith JC. Plexiform xanthomatous tumor, a report of 20 cases in 12 patients. Am J Surg Pathol 2002;26:1302-11.
17. Smith CH, Barker JN, Hay RJ. Diffuse plane xanthomatosis and acquired palmoplantar keratoderma in association with myeloma. Br J Dermatol 1995;132:286-9.
18. Abrams JJ, Grundy SM, Kane JP, Chang CM. Normocholesterolemic dysbetalipoproteinemia with xanthomatosis. Metabolism 1979;28:113-24.
19. Kinoshita M, Kawamura M, Maeda T, Fujimaki Y, Fujita M, Kojima K et al. Apolipoprotein E accelerates the efflux of cholesterol from macrophages: mechanism of xanthoma formation in apolipoprotein E deficiency. J Atheroscler Thromb 2000;6:22-7.
20. Vega GL, Illingworth DR, Grundy SM, Lindgren FT, Connor WE. Normocholesterolemic tendon xanthomatosis with overproduction of apolipoprotein B. Metabolism 1983;32:118-25.
21. Moriyama K, Sasaki J, Takada Y, Matsunaga A, Fukui J, Albers JJ et al. A cysteine-containing truncated apo A-I variant associated with HDL deficiency. Arteriosder Thromb Vasc Biol 1996;16:1416-23.
22. Kuriyama M, Fujiyama J, Yoshidome H, Takenaga S, Matsumuro K, Kasama T et al. Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature. J Neural Sci 1991;102:225-32.
23. von Bahr S, Movin T, Papadogiannakis N, Pikuleva I, Ronnow P, Diczfalusy U et al. Mechanism of accumulation of cholesterol and cholestanol in tendons and the role of sterol 27-hydroxylase (CYP27A1). Arteriosder Thromb Vasc Biol 2002;22:1129-35.
24. Lussier-Cacan S, Cantin M, Roy CC, Sniderman AD, Nestruck AC, Davignon J. Tendon xanthomas associated with cholestanolosis and hyperapobetalipoproteinemia. Clin Invest Med 1986;9:94-9.
25. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000;290:1771-5.
26. Kainberger F, Fialka V, Breitenseher M, Kritz H, Baldt M, Czerny C et al. Differential diagnosis of diseases of the Achilles tendon. A clinico-sonographic concept. Radiologe 1996;36:38-46.
27. Kainberger F, Seidl G, Traindl O, Trattnig S, Breitenseher M, Schneider B et al. Ultrasonography of the Achilles tendon in hypercholesterolemia. Acta Radiol 1993;34:408-12.
28. Tall AR, Small DM, Lees RS. Interaction of collagen with the lipids of tendon xanthomata. J Clin Invest 1978;62:836-46.
29. Kruth HS. Lipid deposition in human tendon xanthoma. Am J Pathol 1985;121:311-5.
30. Bhattacharyya AK, Connor WE, Mausolf FA, Flatt AD. Turnover of xanthoma cholesterol in hyperlipoproteinemia patients. J Lab Clin Med 1976;87:503-18.
31. Ginsberg HN, Goldsmith SJ, Vallabhajosula S. Noninvasive imaging of 99mtechnetium-labeled low density lipoprotein uptake by tendon xanthomas in hypercholesterolemic patients. Arteriosclerosis 1990;10:256-62.
32. Sugiyama N, Marcovina S, Gown AM, Seftel H, Joffe B, Chait A. Immunohistochemical distribution of lipoprotein epitopes in xanthomata from patients with familial hypercholesterolemia. Am J Pathol 1992;141:99-106.
33. Rapp JH, Conner WE, Lin D. Lipids of human atherosclerotic plaques and xanthomas: clue to the mechanism of plaque progression. J Lipid Res 1983;24:1329-35.
34. Mori M, Itabe H, Higashi Y, Fujimoto Y, Shiomi M, Yoshizumi M et al. Foam cell formation containing lipid droplets enriched with free cholesterol by hyperlipidemic serum. J Lipid Res 2001;42:1771-81.
35. Okada M, Miida T, Fujiwara A, Inomata N. Autoantibodies against oxidized low-density lipoprotein correlate with Achilles tendon xanthomas. Clin Chem Lab Med 2000;38:501-6.
36. Inazu A, Koizumi J, Kajinami K, Kiyohar T, Chichibu K, Mabuchi H. Opposite effects on serum cholesteryl ester transfer protein levels between long-term treatments with pravastatin and probucol in patients with primary hypercholesterolemia and xanthoma. Atherosclerosis 1999;145:405-13.
37. Murano S, Shinomiya M, Shirai K, Saito Y, Yoshida S. Characteristic features of long-living patients with familial hypercholesterolemia in Japan. J Am Geriatr Sac 1993;41:253-7.
38. Schmidt HH, Hill S, Makariou EV, Feuerstein IM, Dugi KA, Hoeg JM. Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia. Am J Cardiol 1996;77:575-80.
39. Lehtonen A, Makela P, Viikari J, Virtama P. Achilles tendon hickness in hypercholesterolaemia. Ann Clin Res 1981;13:39-14.
40. Civeira F, Castillo JJ, Calvo C, Ferrando J, de Pedro C, Martinez-Rodes P et al. Achilles tendon size: by high resolution sonography in healthy population. Relationship with lipid Levels. Med Clin (Barc) 1998;111:41-4.
41. Mack WJ, Krauss RM, Hodis HN. Lipoprotein subclass in the monitored atherosclerosis regression study (MARS). Treatment effects and relation to coronary angiographic progression. Arterioscler Thromb Vasc Biol 1996;16:697-704.
42. Yamamoto A, Matsuzawa Y, Yokohama S. Effects of probucol on xanthomata regression in familial hypercholesterolemia. Am J Cardiol 1986;57:29-35.
43. Hata Y, Shigematsu H, Tsushima M, Oikawa T, Yamamoto M, Yamauchi Y et al. Serum lipid and lipoprotein profiles in patients with xanthomas: a correlative study on xanthoma and atherosclerosis (I). Jpn Circ J 1981;45:1236-42.
44. Beaumont V, Jacotot B, Beaumont JL. Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases. Atherosclerosis 1976;24:441-50.
45. Bude RO, Adler RS, Bassett DR, Ikeda DM, Rubin JM. Heterozygous familial hypercholesterolemia: detection of xanthomas in the Achilles tendon with US. Radiology 1993;188:567-71.
46. Bude RO, Nesbitt SD, Adler RS, Rubenfire M. Sonographic detection of xanthomas in normal-sized Achilles' tendons of individuals with heterozygous familial hypercholesterolemia. Am J Roentgenol 1998;170:621-5.
47. Bureau NJ, Roederer G. Sonography of Achilles tendon xanthomas in patients with heterozygous familial hypercholesterolemia. Am J Roentgenol 1998;171:745-9.
48. Yuzama K, Yamakawa K, Tohno E. An ultrasonographic method for detection of Achilles tendon xanthomas in familial hypercholesterolemia. Atherosclerosis 1989;75:211-8.
49. Blomqvist G. Xanthoma of the tendo achilles. Acta Radiol 1962;57:45-8.
50. Blankenhorn DH, Meyers HI. Radiographic determination of Achilles tendon xanthoma size. Metabolism 1969;18:882-6.
51. Dussault RG, Kaplan PA, Roederer G. MR imaging of Achilles tendon in patients with familial hyperlipidemia: Comparison with plain films, physical examination, and patients with traumatic tendon lesions. Am J Roetgenol 1995;164:403-7.
52. Steinmetz A, Schmitt W, Schuler P, Kleinsorge F, Schneider J, Kaffarnik H. Ultrasonography of achilles tendons in primary hypercholesterolemia. Comparison with computed tomography. Atherosclerosis 1988;74:231-9.
53. Kolovou G, Daskalova D, Mastorakou I, Anagnostopoulou K, Cokkinos DV. Regression of Achilles tendon xanthomas evaluated by CT scan after hypolipidemic treatment with simvastatin. A case report. Angiology 2004;55:335-9.
54. Durrington PN, Adams JE, Beastall MD. The assessment of Achilles tendon size in primary hypercholesterolaemia by computed tomography. Atherosclerosis 1982;45:345-58.
55. Bude RO, Adler RS, Bassett DR. Diagnosis of Achilles tendon xanthoma in patients with heterozygous familial hypercholesterolemia: MR vs sonography. Am J Roentgenol 1994;162:913-7.
56. Koivunen-Niemela T, Viikari J, Niinikoski H. Sonography in the detection of achilles tendon xanthomata in children with familial hypercholesterolaemia. Acta Paediatr 1994;83:1178-81.
57. Tuthill TA, Rubin JM, Fowlkes JB. Frequency analysis of echo texture in tendon. Ultrasound Med Biol 1999;25:959-68.
58. Scheel AK, Schettler V, Koziolek M, Koelling S, Werner C, Muller GA et al. Impact of chronic LDL-apheresis treatment on Achilles tendon affection in patients with severe familial hypercholesterolemia: a clinical and ultrasonographic 3-year follow-up study. Atherosclerosis 2004;174:133-9.
59. Ebeling T, Farin P, Pyorala K. Ultrasonography in the detection of Achilles tendon xanthomata in heterozygous familial hypercholesterolemia. Atherosclerosis 1992;97:217-28.
60. Koivunen-Niemela T, Komu M, Viikari J, Alanen A. Magnetic resonance imaging of Achilles tendon xanthomas using a fat-water discrimination technique at 0.1 T. Acad Radiol 1995;2:319-23.
61. Liem MS, Leuven JA, Bloem JL, Schipper J. Magnetic resonance imaging of Achilles tendon xanthomas in familial hypercholesterolemia. Skeletal Radiol 1992;21:453-7.
62. Karaharju E, Paavolainen P, Holmstrom T, Nikkari T. Xanthomas of the Achilles tendon. Ann. Chir Gynaecol 1981;70:116-9.
63. Regnstrom J, Walldius G, Nilsson S, Blinder LS, Johansson J, Molgaard J et al. The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis. Atherosclerosis 1996;125:217-29.
64. Kajinami K, Nishitsuji M, Takeda Y, Shimizu M, Koizumi J, Mabuchi H. Long-term probucol treatment results in regression of xanthomas, but in progression of coronary atherosclerosis in a heterozygous patient with familial hypercholesterolemia. Atherosclerosis 1996;120:181-7.
65. Yamamoto A, Matsuzawa Y, Kishino B. Effects of probucol on homozygous cases of familial hypercholesterolemia. Atherosclerosis 1983;48:157-66.
66. Nakamura T, Ueyama Y, Funahashi T, Yamashita S, Takemura KK, Kubo M et al. Non-macrophage-related accumulation of cholesterol during probucol treatment in familial hypercholesterolemia: report of two cases. Atherosclerosis 1992;92:193-202.
67. Franceschini G, Sirtori M, Vaccarino V, Gianfranceschi G, Rezzonico L, Chiesa G et al. Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer. Arteriosclerosis 1989;9:462-9.
68. Rouffy J, Chanu B, Bakir R, Goy-Loeper J, Djian F, Monsuez JJ et al. Changes in lipid and lipoprotein levels and Achilles tendon diameters and indices in familial hypercholesterolaemic patients with tendinous xanthomatosis treated by diet and bezafibrate for 2 years. Curr Med Res Opin 1988;11:123-32.
69. Muller DP, Pavlou C, Whitelaw AG, McLintock D. The effect of pregnancy and two different contraceptive pills on serum lipids and lipoproteins in a woman with a type III hyperlipoproteinaemia pattern. Br J Obstet Gynaecol 1978;85:127-33.
70. Illingworth DR, Cope R, Bacon SP. Regression of tendon xanthomas in patients with familial hypercholesterolemia treated with lovastatin. South Med J 1990;83:1053-7.
71. Lind S, Olsson AG, Eriksson M, Rudling M, Eggertsen G, Angelin B. Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment. J Intern Med 2004;256:406-12.
72. Mabuchi H, Sakai Y, Watanabe A, Haba T, Koizumi J, Takeda R. Normalization of low-density lipoprotein levels and disappearance of xanthomas during pregnancy in a woman with heterozygous familial hypercholesterolemia. Metabolism 1985;34:309-15.
73. Mabuchi H, Michishita I, Sakai T, Sakai Y, Watanabe A, Wakasugi T et al. Treatment of homozygous patients with familial hypercholesterolemia by double-filtration plasmapheresis. Atherosclerosis 1986;61:135-40.
74. Onaca N, Goldstein RM, Klintmalm GB. Xanthomas disappear rapidly after liver transplantation for familial hypercholesterolemia. Liver Transpl 2003;9:1334-5.
75. Hirobe K, Matsuzawa Y, Ishikawa K, Tarui S, Yamamoto A, Nambu S et al. Coronary artery disease in heterozygous familial hypercholesterolemia. Atherosclerosis 1982;44:201-10.
76. Ferneres J, Lambert J, Lussier-Cacan S, Davignon J. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation. Circulation 1995;92:290-5.
77. Mabuchi H, Tatami R, Haba T, Ueda K, Ueda R, Ito S et al. Achilles tendon thickness and ischemic heart disease in familial hypercholesterolemia. Metabolism 1978;27:1672-9.
78. Elmaleh DR, Narula J, Babich JW, Petrov A, Fischman AJ, Khaw BA et al. Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates. Proc Natl Acad Sci USA 1998;95:691-5.
79. Kruth HS. Localization of unesterified cholesterol in human atherosclerotic lesions. Demonstration of filipin-positive, oil-red-O-negative particles. Am J Pathol 1984;114:201-8.
80. Maggi E, Finardi G, Poli M, Bollati P, Filipponi M, Stefano PL et al. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk. Coron Artery Dis 1993;4:1119-22.
81. Crisby M, Nilsson J, Kostulas V, Bjorkhem I, Diczfalusy U. Localization of sterol 27-hydroxylase immuno-reactivity in human atherosclerotic plaques. Biochim Biophys Acta 1997;1344:278-85.